Found: 71
Select item for more details and to access through your institution.
Emerging trends in immunotherapy for pediatric sarcomas.
- Published in:
- Journal of Hematology & Oncology, 2019, v. 12, n. 1, p. N.PAG, doi. 10.1186/s13045-019-0756-z
- By:
- Publication type:
- Article
Cancer Vaccine Immunotherapy with RNA-Loaded Liposomes.
- Published in:
- International Journal of Molecular Sciences, 2018, v. 19, n. 10, p. 2890, doi. 10.3390/ijms19102890
- By:
- Publication type:
- Article
Melanoma immunotherapy using mature DCs expressing the constitutive proteasome.
- Published in:
- Journal of Clinical Investigation, 2013, v. 123, n. 7, p. 3135, doi. 10.1172/JCI67544
- By:
- Publication type:
- Article
The IDH1 Mutation-Induced Oncometabolite, 2-Hydroxyglutarate, May Affect DNA Methylation and Expression of PD-L1 in Gliomas.
- Published in:
- Frontiers in Molecular Neuroscience, 2018, p. 1, doi. 10.3389/fnmol.2018.00082
- By:
- Publication type:
- Article
The development of dendritic cell vaccine-based immunotherapies for glioblastoma.
- Published in:
- Seminars in Immunopathology, 2017, v. 39, n. 2, p. 225, doi. 10.1007/s00281-016-0616-7
- By:
- Publication type:
- Article
CD4+ and Perivascular Foxp3+ T cells in glioma correlate with opENAccEss angiogenesis and Tumor Progression.
- Published in:
- Frontiers in Immunology, 2017, p. 1, doi. 10.3389/fimmu.2017.01451
- By:
- Publication type:
- Article
Identification of tumor rejection antigens and the immunologic landscape of medulloblastoma.
- Published in:
- Genome Medicine, 2024, v. 16, n. 1, p. 1, doi. 10.1186/s13073-024-01363-y
- By:
- Publication type:
- Article
mRNA-based precision targeting of neoantigens and tumor-associated antigens in malignant brain tumors.
- Published in:
- Genome Medicine, 2024, v. 16, n. 1, p. 1, doi. 10.1186/s13073-024-01281-z
- By:
- Publication type:
- Article
Myeloablative Temozolomide Enhances CD8<sup>+</sup> T-Cell Responses to Vaccine and Is Required for Efficacy against Brain Tumors in Mice.
- Published in:
- PLoS ONE, 2013, v. 8, n. 3, p. 1, doi. 10.1371/journal.pone.0059082
- By:
- Publication type:
- Article
A Pilot Study of IL-2Rα Blockade during Lymphopenia Depletes Regulatory T-cells and Correlates with Enhanced Immunity in Patients with Glioblastoma.
- Published in:
- PLoS ONE, 2012, v. 7, n. 2, p. 1, doi. 10.1371/journal.pone.0031046
- By:
- Publication type:
- Article
Evaluating Efficacy of a Novel Hydrogel-CXCL9-mRNA Vaccine in Combination with Temozolomide in a Murine Glioma Model.
- Published in:
- Journal of Neurosurgery, 2022, v. 136, n. 5, p. 25, doi. 10.3171/2022.5.JNS.AANS2022abstracts
- By:
- Publication type:
- Article
Precision therapeutic targets for COVID-19.
- Published in:
- Virology Journal, 2021, v. 18, n. 1, p. 1, doi. 10.1186/s12985-021-01526-y
- By:
- Publication type:
- Article
Regulatory T cell subsets in patients with medulloblastoma at diagnosis and during standard irradiation and chemotherapy (PBTC N-11).
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 12, p. 1589, doi. 10.1007/s00262-017-2051-6
- By:
- Publication type:
- Article
Increased proportion of FoxP3+ regulatory T cells in tumor infiltrating lymphocytes is associated with tumor recurrence and reduced survival in patients with glioblastoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 4, p. 419, doi. 10.1007/s00262-014-1651-7
- By:
- Publication type:
- Article
A cytokine cocktail directly modulates the phenotype of DC-enriched anti-tumor T cells to convey potent anti-tumor activities in a murine model.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 11, p. 1649, doi. 10.1007/s00262-013-1464-0
- By:
- Publication type:
- Article
BLyS levels correlate with vaccine-induced antibody titers in patients with glioblastoma lymphodepleted by therapeutic temozolomide.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 6, p. 983, doi. 10.1007/s00262-013-1405-y
- By:
- Publication type:
- Article
Survivin as an immunotherapeutic target for adult and pediatric malignant brain tumors.
- Published in:
- Cancer Immunology, Immunotherapy, 2010, v. 59, n. 2, p. 183, doi. 10.1007/s00262-009-0757-9
- By:
- Publication type:
- Article
EGFRvIII-targeted immunotoxin induces antitumor immunity that is inhibited in the absence of CD4+ and CD8+ T cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 1, p. 115, doi. 10.1007/s00262-007-0363-7
- By:
- Publication type:
- Article
Immunotherapy for Pediatric Brain Tumors.
- Published in:
- Brain Sciences (2076-3425), 2017, v. 7, n. 10, p. 137, doi. 10.3390/brainsci7100137
- By:
- Publication type:
- Article
CXCR1- or CXCR2-modified CAR T cells co-opt IL-8 for maximal antitumor efficacy in solid tumors.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41467-019-11869-4
- By:
- Publication type:
- Article
Quantitative characterization of 3D bioprinted structural elements under cell generated forces.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41467-019-10919-1
- By:
- Publication type:
- Article
Lin<sup>−</sup>CCR2<sup>+</sup> hematopoietic stem and progenitor cells overcome resistance to PD-1 blockade.
- Published in:
- Nature Communications, 2018, v. 9, n. 1, p. 1, doi. 10.1038/s41467-018-06182-5
- By:
- Publication type:
- Article
Comment on Mahajan, S.; Schmidt, M.H.H. Distinct Lineage of Slow-Cycling Cells Amidst the Prevailing Heterogeneity in Glioblastoma. Cancers 2023, 15 , 3843.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Association of Suppressive Myeloid Cell Enrichment with Aggressive Oropharynx Squamous Cell Carcinoma.
- Published in:
- Cancers, 2023, v. 15, n. 8, p. 2346, doi. 10.3390/cancers15082346
- By:
- Publication type:
- Article
Slow-Cycling Cells in Glioblastoma: A Specific Population in the Cellular Mosaic of Cancer Stem Cells.
- Published in:
- Cancers, 2022, v. 14, n. 5, p. 1126, doi. 10.3390/cancers14051126
- By:
- Publication type:
- Article
Infiltrative and drug‐resistant slow‐cycling cells support metabolic heterogeneity in glioblastoma.
- Published in:
- EMBO Journal, 2018, v. 37, n. 23, p. N.PAG, doi. 10.15252/embj.201798772
- By:
- Publication type:
- Article
Tracking adoptive T cell immunotherapy using magnetic particle imaging.
- Published in:
- Nanotheranostics, 2021, v. 5, n. 4, p. 431, doi. 10.7150/ntno.55165
- By:
- Publication type:
- Article
Immunotherapy of malignant brain tumors.
- Published in:
- Immunological Reviews, 2008, v. 222, n. 1, p. 70, doi. 10.1111/j.1600-065X.2008.00603.x
- By:
- Publication type:
- Article
Metabolomics Monitoring of Treatment Response to Brain Tumor Immunotherapy.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.691246
- By:
- Publication type:
- Article
Unique challenges for glioblastoma immunotherapy—discussions across neuro-oncology and non-neuro-oncology experts in cancer immunology. Meeting Report from the 2019 SNO Immuno-Oncology Think Tank.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 3, p. 356, doi. 10.1093/neuonc/noaa277
- By:
- Publication type:
- Article
Adult immuno-oncology: using past failures to inform the future.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 9, p. 1249, doi. 10.1093/neuonc/noaa116
- By:
- Publication type:
- Article
Modulation of temozolomide dose differentially affects T-cell response to immune checkpoint inhibition.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 6, p. 730, doi. 10.1093/neuonc/noz015
- By:
- Publication type:
- Article
IMMU-08. UNLOCKING CANCER IMMUNOTHERAPY AGAINST PEDIATRIC BRAIN TUMORS WITH TRANSCRIPTOME LOADED NANOPARTICLES.
- Published in:
- Neuro-Oncology, 2019, v. 21, p. ii94, doi. 10.1093/neuonc/noz036.129
- By:
- Publication type:
- Article
IMMU-07. IMMUNOLOGIC TARGETING OF DIPG WITH H3K27M ENCODING RNA-NANOPARTICLES.
- Published in:
- Neuro-Oncology, 2019, v. 21, p. ii94, doi. 10.1093/neuonc/noz036.128
- By:
- Publication type:
- Article
BSTM-03. INCREASING ANTI-TUMOR T CELL ACTIVATION, VELOCITY, AND MIGRATION TO BRAIN STEM GLIOMA USING HEMATOPOIETIC STEM AND PROGENITOR CELLS.
- Published in:
- Neuro-Oncology, 2019, v. 21, p. ii67, doi. 10.1093/neuonc/noz036.020
- By:
- Publication type:
- Article
Temozolomide for immunomodulation in the treatment of glioblastoma.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 12, p. 1566, doi. 10.1093/neuonc/noy072
- By:
- Publication type:
- Article
TMIC-29. REPROGRAMMING BONE MARROW OF TUMOR-BEARING HOSTS FOR GLIOMA IMMUNOTHERAPY.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi262, doi. 10.1093/neuonc/noy148.1088
- By:
- Publication type:
- Article
TMIC-12. TUMOR-HOMING RNA-NANOPARTICLES REPROGRAM IMMUNE CELLS IN THE BRAIN TUMOR MICROENVIRONMENT.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi258, doi. 10.1093/neuonc/noy148.1071
- By:
- Publication type:
- Article
PDCT-08. TRACKING THE T CELL REPERTOIRE AFTER ADOPTIVE CELL THERAPY IN PEDIATRIC PATIENTS WITH RECURRENT MEDULLOBLASTOMA.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi202, doi. 10.1093/neuonc/noy148.838
- By:
- Publication type:
- Article
DRES-13. VEGF BLOCKADE ENHANCES T REGULATORY CELL FUNCTION BY DYSREGULATING GLUTAMATE TRANSPORT IN GBM.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi78, doi. 10.1093/neuonc/noy148.320
- By:
- Publication type:
- Article
IMMU-67. PERSONALIZED TUMOR MRNA LOADED LIPID NANOPARTICLES PRIME THE SYSTEMIC AND INTRATUMORAL GBM MILIEU FOR RESPONSE TO IMMUNOTHERAPY.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi136, doi. 10.1093/neuonc/noy148.570
- By:
- Publication type:
- Article
IMMU-66. A NOVEL METABOLITE TO INCREASE EFFICACY OF CELLULAR IMMUNOTHERAPY IN THE TREATMENT OF GLIOBLASTOMA.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi136, doi. 10.1093/neuonc/noy148.569
- By:
- Publication type:
- Article
IMMU-56. CXCR1/2 MODIFIED CARs CO-OPT RADIATION-INDUCED IL-8 FOR ENHANCED CHEMOTAXIS OF THE CAR T CELLS AND MAXIMAL ANTI-TUMOR EFFICACY.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi134, doi. 10.1093/neuonc/noy148.559
- By:
- Publication type:
- Article
MicroRNAs provide a novel pathway toward combinatorial immune checkpoint blockade.
- Published in:
- Neuro-Oncology, 2016, v. 18, n. 5, p. 601, doi. 10.1093/neuonc/now003
- By:
- Publication type:
- Article
Vaccination strategies for neuro-oncology.
- Published in:
- Neuro-Oncology, 2015, v. 17, p. vii15, doi. 10.1093/neuonc/nov159
- By:
- Publication type:
- Article
RANDOMIZATION OF PATIENTS WITH GLIOBLASTOMA TO VACCINE SITE PRE-CONDITIONING WITH TETANUS-DIPHTHERIA TOXOID SYSTEMICALLY ENHANCES MIGRATION AND THERAPEUTIC EFFECT OF CYTOMEGALOVIRUS PP65-PULSED DENDRITIC CELL VACCINE IN A MIP-1α-DEPENDENT FASHION.
- Published in:
- Neuro-Oncology, 2014, v. 16, n. suppl_3, p. iii39, doi. 10.1093/neuonc/nou208.63
- By:
- Publication type:
- Article
Greater chemotherapy-induced lymphopenia enhances tumor-specific immune responses that eliminate EGFRvIII-expressing tumor cells in patients with glioblastoma.
- Published in:
- Neuro-Oncology, 2011, v. 13, n. 3, p. 324, doi. 10.1093/neuonc/noq157
- By:
- Publication type:
- Article
Contemporary RNA Therapeutics for Glioblastoma.
- Published in:
- NeuroMolecular Medicine, 2022, v. 24, n. 1, p. 8, doi. 10.1007/s12017-021-08669-9
- By:
- Publication type:
- Article
Immunotherapy for Brain Tumors.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Proteomic and immunologic analyses of brain tumor exosomes.
- Published in:
- FASEB Journal, 2009, v. 23, n. 5, p. 1541, doi. 10.1096/fj.08-122184
- By:
- Publication type:
- Article